Vaccines and Immunomodulatory Therapies for Tularemia
The present invention relates to attenuated strains of Francisella tularensis from which genes in the guanine nucleotide biosynthetic pathway have been deleted and to methods for making the mutants. The invention further relates to the use of the attenuated strains to make vaccines.
Patents:US 20,110,020,399
Inventor(s):
SANTIAGO ARACELI [US]; LEVINE MYRON M [US]; BARRY EILEEN M [US]
Type of Offer:
Licensing
« More Biotech Patents